Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2008-10-29
2011-10-04
Henley, III, Raymond (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S667000, C514S668000
Reexamination Certificate
active
08030358
ABSTRACT:
A composition for removing a radioactive element or compound such as systemic transuranic compounds, from mammals comprises a pharmaceutical carrier and a decorporation agent comprising ester and amide derivatives of DTPA. A method of treating a mammal to remove systemic compounds utilizing the DTPA derivatives is also disclosed.
REFERENCES:
patent: 4687659 (1987-08-01), Quay
patent: 4780238 (1988-10-01), Premuzic
patent: 4859451 (1989-08-01), Quay et al.
patent: 5250702 (1993-10-01), Kondo et al.
patent: 5288718 (1994-02-01), Varga et al.
patent: 5403862 (1995-04-01), Miller et al.
patent: 5440031 (1995-08-01), Varga et al.
patent: 5494935 (1996-02-01), Miller et al.
patent: 5780670 (1998-07-01), Yamamoto et al.
patent: 6020373 (2000-02-01), Schellenberg et al.
patent: 6060040 (2000-05-01), Tournier et al.
patent: 6241968 (2001-06-01), Tournier et al.
patent: 2007/0196273 (2007-08-01), Shankar et al.
U.S. Food and Drug Administration, FDA News, FDA Approves Drugs to Treat Internal Contamination from Radioactive Elements, Aug. 11, 2004, www.fda.gov/bbs/topics
ews/2004/NEW01103.html.
Depatment of Health and Human Services, CDC Fact Sheet, Diethylenetriamene pentaacetate (DTPA), Oct. 11, 2006.
Radiation Event Medical Management, Ca-DTPA/Zn-DTPA (Diethylentriamene pentaacetate), Jul. 25, 2007, www.remm.nlm.gov/dtpa.htm.
Jay Michael
Mumper Russell J.
Henley III Raymond
King & Schickli PLLC
University of Kentucky Research Foundation
LandOfFree
Methods and pharmaceutical compositions for decorporation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and pharmaceutical compositions for decorporation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and pharmaceutical compositions for decorporation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4278491